Oxygenta Pharmaceutical Secures Land Allotment for Rs 6.75 Crore in Telangana
Oxygenta Pharmaceutical Ltd 路 Others (Uncategorized) 路 01 Oct 2026, 11:28 pm
Oxygenta Pharmaceutical Secures Land Allotment for Rs 6.75 Crore in Telangana Telangana Industrial Infrastructure Corporation Limited issued a final allotment letter on 1st Oct'26 to Oxygenta Pharmaceutical Limited for 36,421 sq. meters of land (Plot No. UDL-1) at UDL-Aroor, Sangareddy District, Telangana. The transaction entails a total consideration of Rs 6.75 crore (Rs 6,75,24,534). The acquisition aims to support ongoing business operations, facilitate future capacity expansion, and build infrastructure to meet long-term strategic growth requirements.
Original exchange filing (PDF)
More announcements from Oxygenta Pharmaceutical Ltd
- Un-audited Financial Results for the Quarter and Half-year ended 30.09.2026. 路 10 Nov 2026
- Outcome of Board Meeting held on Tuesday i.e. 10th November, 2026. 路 10 Nov 2026
- Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2026 ,inter alia, to consider and approve 1. Un-audited Financial .... 路 10 Nov 2026
- Disclosure under Regulation 44(3) of SEBI (LODR), Regulations, 2015. 路 21 Aug 2026
- Outcome of 33rd Annual General Meeting held on 21.08.2026. 路 21 Aug 2026
- Newspaper Advertisement for Notice of AGM scheduled to be held on 21st August, 2026. 路 31 Jul 2026
- Intimation of Book Closure and Cut-off Date for the AGM 路 30 Jul 2026
- Submission of 33rd Annual Report for the Financial Year 2025-26 under Regulation 34 of SEBI (LODR), Regulations, 2015 路 30 Jul 2026
